Evidence map›Paper›PMID 26949061›Full record

ArticleScientific reports2016

Neutralizing Monoclonal Antibodies against Disparate Epitopes on Ricin Toxin's Enzymatic Subunit Interfere with Intracellular Toxin Transport.

Anastasiya Yermakova, Tove Irene Klokk, Joanne M O'Hara, Richard Cole, Kirsten Sandvig, Nicholas J Mantis

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Anastasiya YermakovaDivision of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY 12208.
Tove Irene KlokkDepartment of Molecular Cell Biology, Centre for Cancer Biomedicine, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Oslo, Norway.
Joanne M O'HaraDivision of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY 12208.
Richard ColeDepartment of Biomedical Sciences, School of Public Health, University at Albany, Albany, NY 12201.
Kirsten SandvigDepartment of Molecular Cell Biology, Centre for Cancer Biomedicine, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Oslo, Norway.
Nicholas J MantisDivision of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY 12208.
New York State Department of Health · USNorwegian Cancer Society · NOOslo University Hospital · NOUniversity at Albany, State University of New York · US

Funding

Training in Biodefense and Emerging Infectious DiseaseT32AI055429 · NIAID · WADSWORTH CENTER · PI MCDONOUGH, KATHLEEN A · 2004 to 2014
$2.2M
Ricin toxin: Neutralizing antibodies and vaccine designR03AI097688 · NIAID · WADSWORTH CENTER · PI MANTIS, NICHOLAS J. · 2012 to 2013
$136k
NIAID NIH HHS AI097688NIAID NIH HHS HHSN272201400021CNIAID NIH HHS R03 AI097688NIAID NIH HHS T32 AI055429NIAID NIH HHS T32AI055429PHS HHS HHSN272201400021C
6 · The paper itself

Abstract

Ricin is a member of the A-B family of bacterial and plant toxins that exploit retrograde trafficking to the Golgi apparatus and endoplasmic reticulum (ER) as a means to deliver their cytotoxic enzymatic subunits into the cytoplasm of mammalian cells. In this study we demonstrate that R70 and SyH7, two well-characterized monoclonal antibodies (mAbs) directed against distinct epitopes on the surface of ricin's enzymatic subunit (RTA), interfere with toxin transport from the plasma membrane to the trans Golgi network. Toxin-mAb complexes formed on the cell surface delayed ricin's egress from EEA-1(+) and Rab7(+) vesicles and enhanced toxin accumulation in LAMP-1(+) vesicles, suggesting the complexes were destined for degradation in lysosomes. Three other RTA-specific neutralizing mAbs against different epitopes were similar to R70 and SyH7 in terms of their effects on ricin retrograde transport. We conclude that interference with toxin retrograde transport may be a hallmark of toxin-neutralizing antibodies directed against disparate epitopes on RTA.

Indexed as

AnimalsAntibodies, MonoclonalAntitoxinsChemical Warfare AgentsChlorocebus aethiopsEpitopesHeLa CellsHumansImmunologic FactorsProtein BindingProtein TransportRicinVero CellsAntibodies, MonoclonalAntitoxinsChemical Warfare AgentsEpitopesImmunologic FactorsRicin

Identifiers

PMID26949061
PMCPMC4779987
OpenAlexW2304734761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.